Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Non-cash Items of $72000.0 in Q1 2026, down 99.64% quarter-over-quarter from $20.0 million in Q4 2025, and down 98.89% on a YoY basis from $6.5 million in Q1 2025.
Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2026) Analysis & Trends
Organogenesis Holdings' Non-cash Items history runs 6 years deep, the most recent figure standing at $72000.0 for Q1 2026.
- In Q1 2026, Non-cash Items fell 98.89% year-over-year to $72000.0; the TTM figure through Mar 2026 stood at $72000.0 (down 98.89% YoY), while the FY2025 annual figure was $6.3 million, up 148.65% from the prior year.
- Non-cash Items was $72000.0 for Q1 2026 at Organogenesis Holdings, down from $20.0 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $20.0 million in Q4 2025 to a low of $72000.0 in Q1 2026.
- Historically, Non-cash Items has averaged $5.3 million across 5 years, with a median of $4.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Non-cash Items soared 692.26% in 2025, then plunged 98.89% in 2026.
- A 5-year view of Non-cash Items shows it stood at $2.2 million in 2022, then jumped by 357.33% to $10.3 million in 2023, then tumbled by 75.45% to $2.5 million in 2024, then jumped by 692.26% to $20.0 million in 2025, then slumped by 99.64% to $72000.0 in 2026.
- The last three Non-cash Items figures came in at $72000.0 (Q1 2026), $20.0 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 19.97 Mn |
| Dec 31, 2025 | 19.97 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Mar 31, 2025 | 6.46 Mn |
| Mar 31, 2025 | 6.46 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 5.26 Mn |
| Mar 31, 2024 | 5.26 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Dec 31, 2023 | 10.27 Mn |